Additionally, we evaluated the mutation frequency of HBV-HCC patients between different risk groups (Figures 8F, G), showing that TP53 had the highest mutation frequency, with a significant difference in mutation frequency between high-risk and low-risk groups. Here, TP53 is linked to hepatocellular carcinoma.